MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$25,310M
Net Income
$5,534M
Net Profit Margin
21.86%
EPS
$2.27
Unit: Million (M) dollars
Revenue Breakdown
Innovative Medicine
Med Tech
Revenue Breakdown
US
Europe
Asia Pacific Africa
Western Hemisphere Excluding US
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-28
2026-03-29
2025-12-28
2025-09-28
Sales to customers (note 9)
25,310
24,062
24,564
23,993
Cost of products sold
8,051
8,106
7,968
7,303
Gross profit
17,259
15,956
16,596
16,690
Selling, marketing and administrative expenses
6,432
6,034
6,753
5,922
Research and development expense
3,653
3,527
4,252
3,672
In-process research and development impairments
-
36
81
-
Interest income
219
229
237
227
Interest expense, net of portion capitalized
281
272
214
245
Other (income) expense, net
-331
-294
-483
478
Restructuring (note 12)
34
32
84
63
Earnings before provision for taxes on income
6,747
5,990
4,966
7,493
Provision for taxes on income (note5)
1,213
755
-150
2,341
Net earnings from continuing operations
-
-
5,116*
-
Net earnings from discontinued operations
-
-
0*
-
Net earnings
5,534
5,235
5,116
5,152
Basic EPS
2.3
2.17
2.125
2.14
Diluted EPS
2.27
2.14
2.091
2.12
Basic Average Shares
2,407,400,000
2,408,700,000
2,407,800,000
2,408,300,000
Diluted Average Shares
2,440,100,000
2,445,200,000
2,446,100,000
2,428,600,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
JNJ Income Statement Sankey Diagram
Sankey diagram visualizing JNJ income statement for the period
Innovative Medicine
$16,384M
(7.78%↑ Y/Y)
Med Tech
$8,926M
(4.51%↑ Y/Y)
Sales to customers
(note 9)
$25,310M
(6.60%↑ Y/Y)
Gross profit
$17,259M
(7.10%↑ Y/Y)
Interest income
$219M
(-15.77%↓ Y/Y)
Cost of products sold
$8,051M
(5.55%↑ Y/Y)
Earnings before
provision for taxes on...
$6,747M
(3.94%↑ Y/Y)
Selling, marketing and
administrative expenses
$6,432M
(9.22%↑ Y/Y)
Research and development
expense
$3,653M
(3.90%↑ Y/Y)
Other (income)
expense, net
-$331M
(-209.35%↓ Y/Y)
Interest expense, net of
portion capitalized
$281M
(-8.77%↓ Y/Y)
Restructuring (note 12)
$34M
(-46.88%↓ Y/Y)
Net earnings
$5,534M
(-0.05%↓ Y/Y)
Provision for taxes on
income (note5)
$1,213M
(27.15%↑ Y/Y)
Buy us a coffee
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
Show more